๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients

โœ Scribed by Richard M. Elledge; Daniel R. Ciocca; Gregory Langone; William L. McGuire

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
802 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Histochemical assay of estrogen and prog
Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies
โœ Louis P. Pertschuk; Ellis H. Tobin; Eric Gaetjens; Anne C. Carter; George A. Deg ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 697 KB

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp

Resistance to tamoxifen-induced apoptosi
Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer
โœ Yih-Lin Chung; Meei-Ling Sheu; Shun-Chun Yang; Chi-Hung Lin; Sang-Hue Yen ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 498 KB

## Abstract Overexpression of Her2/neu is implicated in the development of resistance to the antiestrogen tamoxifen (TAM) that exerts its inhibitory effect through interaction with estrogen receptor (ER). Whereas Her2/neu and ER are believed to be important cell survival/death factors in human brea